Pyrls

Cloud-based practical drug information platform for providers

placeMinneapolis, Minnesota, United States calendar_todayFounded 2018 language pyrls.com

Social engagement

Social engagement: 13.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record; lead investors include Y Combinator.

Investor typeCountShare
Venture capital2100%

Recent activity

30 Jun 2026
Product launch
Pyrls NAPLEX Virtual Testing Center
11 Jun 2026
Product launch
Q8W Dosing Regimen for EBGLYSS (lebrikizumab-lbkz)
1 Jun 2026
Product launch
ZAYNICH (cefepime/zidebactam)
Coming soon